Učitavanje...
CD38-Directed Therapies for Management of Multiple Myeloma
The survival outcomes for multiple myeloma have improved several-fold in the past two decades, primarily due to the introduction of therapies with novel mechanisms of action including immunomodulatory agents, proteasome inhibitors, stem cell transplant and monoclonal antibodies in the schema of ther...
Spremljeno u:
| Izdano u: | Immunotargets Ther |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8254545/ https://ncbi.nlm.nih.gov/pubmed/34235096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S259122 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|